Healthcare -
Biotechnology - NASDAQ - US
$ 31.49
-0.317 %
$ 14 B
Market Cap
12.4
P/E
RPRX - CASH & EQUIVALENTS
Cash & Equivalents RPRX - Royalty Pharma plc
477 M
LAST VALUE
-44.36%
2 YEAR CAGR
-24.34%
5 YEAR CAGR
0.00%
10 YEAR CAGR